ECMO for Respiratory Failure Related to COVID-19

Extracorporeal Membrane Oxygenation for Respiratory Failure Related to COVID-19

A Nationwide Cohort Study

Nicolas Nesseler, M.D., Ph.D.; Guillaume Fadel, M.D.; Alexandre Mansour, M.D.; Marylou Para, M.D.; Pierre-Emmanuel Falcoz, M.D., Ph.D.; Nicolas Mongardon, M.D., Ph.D.; Alizée Porto, M.D.; Astrid Bertier, M.D.; Bruno Levy, M.D., Ph.D.; Cyril Cadoz, M.D.; Pierre-Grégoire Guinot, M.D., Ph.D.; Olivier Fouquet, M.D., Ph.D.; Jean-Luc Fellahi, M.D., Ph.D.; Alexandre Ouattara, M.D., Ph.D.; Julien Guihaire, M.D., Ph.D.; Vito-Giovanni Ruggieri, M.D., Ph.D.; Philippe Gaudard, M.D., Ph.D.; François Labaste, M.D., Ph.D.; Thomas Clavier, M.D.; Kais Brini, M.D.; Nicolas Allou, M.D.; Corentin Lacroix, M.D.; Juliette Chommeloux, M.D.; Guillaume Lebreton, M.D., Ph.D.; Michael A. Matthay, M.D., Ph.D.; Sophie Provenchere, M.D., Ph.D.; Erwan Flécher, M.D., Ph.D.; André Vincentelli, M.D., Ph.D.

Disclosures

Anesthesiology. 2022;136(5):732-748. 

In This Article

Abstract and Introduction

Abstract

Background: Despite expanding use, knowledge on extracorporeal membrane oxygenation support during the COVID-19 pandemic remains limited. The objective was to report characteristics, management, and outcomes of patients receiving extracorporeal membrane oxygenation with a diagnosis of COVID-19 in France and to identify pre-extracorporeal membrane oxygenation factors associated with in-hospital mortality. A hypothesis of similar mortality rates and risk factors for COVID-19 and non–COVID-19 patients on venovenous extracorporeal membrane oxygenation was made.

Methods: The Extracorporeal Membrane Oxygenation for Respiratory Failure and/or Heart failure related to Severe Acute Respiratory Syndrome-Coronavirus 2 (ECMOSARS) registry included COVID-19 patients supported by extracorporeal membrane oxygenation in France. This study analyzed patients included in this registry up to October 25, 2020, and supported by venovenous extracorporeal membrane oxygenation for respiratory failure with a minimum follow-up of 28 days after cannulation. The primary outcome was in-hospital mortality. Risk factors for in-hospital mortality were analyzed.

Results:Among 494 extracorporeal membrane oxygenation patients included in the registry, 429 were initially supported by venovenous extracorporeal membrane oxygenation and followed for at least 28 days. The median (interquartile range) age was 54 yr (46 to 60 yr), and 338 of 429 (79%) were men. Management before extracorporeal membrane oxygenation cannulation included prone positioning for 411 of 429 (96%), neuromuscular blockage for 419 of 427 (98%), and NO for 161 of 401 (40%).

Recommendations

processing....